Qure.ai
AI assistance for accelerated healthcare — the world's most adopted healthcare AI.
Overview
Qure.ai's strength is global scale in image-based screening, particularly chest X-ray and TB/lung disease detection, which has made it a go-to AI vendor for public health programs, NHS deployments, and pharma-backed clinical trials, not just single hospitals. It claims 45M+ lives impacted and over a billion training images, which points to a maturity and breadth of validation that's rare among medical imaging AI startups.
The tradeoff is the same one every enterprise health AI vendor shares: no public pricing, and real value only shows up after integration into a health system's existing imaging and reporting pipeline. Compared to Aidoc, which leans toward acute-care triage across multiple specialties in developed-market hospitals, Qure.ai has a stronger footprint in population-level screening and global health settings, making the two more complementary than directly competing in many buying scenarios.
Key Features
qXR: AI-powered chest X-ray analysis and reporting for TB, lung nodules, and other findings.
qTrack: AI-powered reporting and collaboration platform for screening programs and case management.
Lung Nodule Management: early detection and longitudinal tracking of disease progression.
Stroke & TBI Care Suite: patient triage and care coordination for time-critical neuro emergencies.
MSK X-Ray Reporting: AI-assisted musculoskeletal imaging analysis.
Heart Failure Screening: cardiac care support built into imaging workflows.
Pricing
Starting price
Custom pricing only, contact sales
Enterprise/Custom: pricing is not published; hospitals, health systems, and public health programs receive a custom quote.
Disclaimer: pricing may change, confirm on Qure.ai's own pricing/sales page before buying.
Pros
Massive real-world scale: deployed across 5,500+ sites in 105+ countries with 45M+ lives impacted.
Strong public health footprint: widely used in TB screening and population health programs, not just hospital acute care.
Broad product line: covers chest X-ray, stroke/TBI, MSK, and cardiac use cases.
Pharma/clinical trial support: extends beyond hospital care into life sciences use cases.
Cons
No public pricing: enterprise sales process required for a quote.
Enterprise-only: not usable by individual clinicians or small practices.
Integration-dependent: outcomes depend on how well it's embedded into existing radiology/screening workflows.
What Makes It Unique
Unique Angle: Qure.ai's differentiator is global public-health scale — its chest X-ray and TB screening AI is deployed across more countries and screening programs than most competitors, making it especially strong for population-level and resource-constrained healthcare settings.
Kay Score
7.5
/ 10
